A first time supportive response of Photobiomodulation Therapy | Low Level Laser | Cold Laser Therapy on Covid-19 has been published in the USA.

Sigman, Scott & Mokmeli, Soheila & Monici, Monica & Vetrici, Mariana. (2020). A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19. American Journal of Case Reports. 21. 10.12659/AJCR.926779. Coronavirus disease 2019 (COVID-19) is associated with lung inflammation and cytokine storm. Photobiomodulation | cold laser therapy (PBMT) is a safe, non-invasive therapy with significant anti-inflammatory effects. Adjunct PBMT has been employed in treating patients with lung conditions. Human studies and experimental models of respiratory disease suggest PBMT reduces inflammation and promotes lung healing. This is the first time supportive PBMT was used in a severe case of COVID-19 pneumonia.

A 57-year-old African American man with severe COVID-19 received 4 once-daily cold laser sessions. The patient was evaluated before and after treatment via radiological assessment of lung edema (RALE) by CXR, pulmonary severity indices, blood tests, oxygen requirements, and patient questionnaires. Oxygen saturation (SpO2 ) increased from 93–94% to 97–100%, while the oxygen requirement decreased from 2–4 L/min to 1 L/min. The RALE score improved from 8 to 5. The Pneumonia Severity Index improved from Class V (142) to Class II (67). Additional pulmonary indices (Brescia-COVID and SMART-COP) both decreased from 4 to 0. CRP normalised from 15.1 to 1.23. The patient reported substantial improvement in the Community-Acquired Pneumonia assessment tool.

This report has presented supportive PBMT in a patient with severe COVID-19 pneumonia. Respiratory indices, radiological findings, oxygen requirements, and patient outcomes improved over several days and without need for a ventilator. Future controlled clinical trials are required to evaluate the effects of PBMT on clinical outcomes in patients with COVID-19 pneumonia.

We look forward to receiving further news relating to Cold Laser Therapy on Covid-19 as further research builds.

Read the full report here: Low Level Laser Therapy on Covid-19

BOOK A CONSULTATION

Ruth Phypers

Ruth Phypers combines extensive health and recovery expertise with Low Level Laser Therapy (Cold Laser / PBM) technology. Ruth Phypers is an expert in therapeutic laser protocols developed over 30 years of extensive research. She runs a Harley Street medical practice in Therapeutic Laser medicine (Low Level Laser Therapy | Photobiomodulation) focusing on general health, fertility, thyroid, pain relief, nerve damage, neurodegenerative disease and youthful ageing.